We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$48.7B
AUM Growth
+$5.31B
Cap. Flow
+$590M
Cap. Flow %
1.21%
Top 10 Hldgs %
24.57%
Holding
1,555
New
71
Increased
554
Reduced
469
Closed
82

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$115M
2
CVX icon
Chevron
CVX
+$94.8M
3
UNP icon
Union Pacific
UNP
+$86.5M
4
MSFT icon
Microsoft
MSFT
+$80.6M
5
DELL icon
Dell
DELL
+$78.4M

Sector Composition

Rank Sector Weight
1 Technology 28.66%
2 Healthcare 17.31%
3 Financials 10.36%
4 Consumer Discretionary 9.98%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIZ icon
901
Assurant
AIZ
$13.9B
$993K ﹤0.01%
5,950
-86
-1% -$13.7K
IBRX icon
902
ImmunityBio
IBRX
$8.12B
$993K ﹤0.01%
196,200
FOX icon
903
Fox Class B
FOX
$23B
$985K ﹤0.01%
36,235
+1,041
+3% +$29.2K
DKNG icon
904
DraftKings
DKNG
$12.5B
$984K ﹤0.01%
27,630
-153
-0.6% -$5.12K
FDMT icon
905
4D Molecular Therapeutics
FDMT
$601M
$966K ﹤0.01%
+46,000
New +$605K
DOLE icon
906
Dole
DOLE
$1.23B
$962K ﹤0.01%
77,162
-56,000
-42% -$647K
LBTYK icon
907
Liberty Global Class C
LBTYK
$3.4B
$955K ﹤0.01%
52,868
+1,823
+4% +$31.6K
FSV icon
908
FirstService
FSV
$6.25B
$950K ﹤0.01%
5,891
+538
+10% +$81.3K
MUSA icon
909
Murphy USA
MUSA
$9.82B
$946K ﹤0.01%
2,664
-226
-8% -$81.9K
PK icon
910
Park Hotels & Resorts
PK
$2.91B
$945K ﹤0.01%
60,679
-12,991
-18% -$179K
AU icon
911
AngloGold Ashanti
AU
$50.9B
$936K ﹤0.01%
50,000
-5,500
-10% -$99.2K
RGA icon
912
Reinsurance Group of America
RGA
$15.9B
$935K ﹤0.01%
5,797
VRNS icon
913
Varonis Systems
VRNS
$4.83B
$932K ﹤0.01%
20,500
TENB icon
914
Tenable Holdings
TENB
$4.13B
$931K ﹤0.01%
20,000
-12,000
-38% -$505K
SUPN icon
915
Supernus Pharmaceuticals
SUPN
$2.73B
$926K ﹤0.01%
31,775
EWTX icon
916
Edgewise Therapeutics
EWTX
$4.74B
$920K ﹤0.01%
80,000
PCRX icon
917
Pacira BioSciences
PCRX
$964M
$918K ﹤0.01%
27,515
PINC
918
DELISTED
Premier
PINC
$916K ﹤0.01%
42,100
-11,500
-21% -$238K
INBX
919
DELISTED
Inhibrx, Inc. Common Stock
INBX
$916K ﹤0.01%
26,400
BE icon
920
Bloom Energy
BE
$72.8B
$906K ﹤0.01%
58,517
+2,379
+4% +$29.8K
AGIO icon
921
Agios Pharmaceuticals
AGIO
$1.95B
$901K ﹤0.01%
40,000
EXLS icon
922
EXL Service
EXLS
$5.22B
$900K ﹤0.01%
29,530
-28,245
-49% -$800K
CUZ icon
923
Cousins Properties
CUZ
$4.85B
$895K ﹤0.01%
36,511
ERIE icon
924
Erie Indemnity
ERIE
$13.3B
$891K ﹤0.01%
2,706
-228
-8% -$68.5K
EQT icon
925
EQT Corp
EQT
$33.9B
$873K ﹤0.01%
22,564
+2,201
+11% +$89.3K

Similar funds

DekaBank Deutsche Girozentrale's Q4 2023 Portfolio in Review

As of Q4 2023, DekaBank Deutsche Girozentrale held 1,555 positions worth $48.7B, up 12% from $43.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

DekaBank Deutsche Girozentrale's Q4 2023 filing shows 71 new, 554 increased, 469 reduced and 82 closed positions. Its largest new stake was Veralto: 727,445 shares worth $59.9M. The largest sale was UnitedHealth, an estimated $107M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • DekaBank Deutsche Girozentrale's largest Q4 2023 buy was Veralto: 727,445 shares worth $59.9M.
  • DekaBank Deutsche Girozentrale added most to Broadcom in Q4 2023, an estimated $115M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $107M.
  • DekaBank Deutsche Girozentrale fully exited Activision Blizzard in Q4 2023, selling an estimated $50.4M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 25% of its $48.7B portfolio in Q4 2023.
  • DekaBank Deutsche Girozentrale opened 71 new positions and closed 82 in Q4 2023.
  • DekaBank Deutsche Girozentrale's portfolio value rose 12% quarter-over-quarter to $48.7B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2023, filed 24 Jan 2024.